
Knee Implants Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
- Transparency Market Research
- Ongoing
- Biotechnology
Report Description
Knee implant procedures are done when a
patient has knee pain, a traumatic injury or a disability from rheumatoid
arthritis, or osteoarthritis. In the surgical process, a surgeon implants
the device (artificial device) and replaces the damaged knee with it.
There are many different types of implants - which are made of metal
alloys, strong plastic parts or ceramic material.
The knee implants market will grow due
to factors such as increase in the rate of age related diseases like
osteoporosis and arthritis, diabetes, obesity, ageing population and
injuries related to sports. However due to technological advances such as
minimal invasive surgery, better implant materials and better success
rates, even the younger population are able to undergo knee replacement
surgery.
Technological advancements in knee
implants such as minimally invasive surgery have made it possible to have
procedures with small incisions, lower blood loss, lesser tissue injuries
and faster recovery time. Growing awareness among patients regarding their
health will also help to drive the market.
The knee implants market has had to
face some challenges due to the economic slowdown. This has resulted in
many hospitals cutting down their costs to increase their market share.
Many patients are reluctant to go in for knee implantation procedures due
to the high cost involved. Further, the knee implant market is also
showing pressure due to the intense competition among manufacturers on the
prices.
Presently, in this emerging market,
both patients and surgeons have more options for implant due to the newer
available techniques which are giving better outcomes for patients. This
has given options for implant manufacturers companies to provide new
product solutions.
The global knee implants market was
USD 8.4 billion in 2011 and it is forecasted that this market will reach
USD 15 billion in 2018 with compound annual growth rate of 8.64% during
2011 to 2018. The U.S. and Europe are the two big markets for knee
implants and both the countries enjoy more than 70% market share of global
knee implants.
The leading players in the knee
implants market are B.Braun, Smith and Nephew, Stryker, Zimmer, and Depuy.
They accounted for almost 80% of the total market. Zimmer is the market
leader among them with 30% market share. The medical device manufacturing
companies are increasing their market share with marketing campaigns and
awareness.
This market research report analyzes
important market segments, and major geographies. This report is a
complete study of current trends in the market, industry growth drivers,
and restraints. It provides market projections for the coming years. It
includes analysis of recent developments in technology, Porter’s five
force model analysis and detailed profiles of top industry players. The
report also includes a review of micro and macro factors essential for the
existing market players and new entrants along with detailed value chain
analysis.
The major regions analyzed under this
research study are North America, Asia-Pacific, Europe, and the Rest of the
World.
Reasons for Buying this
Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
Have query on this report?
Make an EnquirySuccess Stories
Our Clients






More from Biotechnology

Popular Reports

Pharmaceuticals and Healthcare
Global Bionic Ears Market Professional Survey Report 2017Pharmaceuticals and Healthcare
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017Pharmaceuticals and Healthcare
Hepatitis Drug Development Pipeline Review, 2017